Methods for the diagnosis and thetreatment of graft-versus-hostdisease

The invention relates to methods for the prediction and the treatment of risk of acute graft versus host disease. The inventors demonstrated that an alteration of CD73-mediated regulatory function of DP8? Tregs could contribute to the acute GvHD pathophysiology. In particular, the present invention relates to method of determining whether a subject has or is at a risk of developing graft-versus-host disease (GvHD) comprising the steps of: i) determining the level of CD73 expression by DP8? TREGS in a sample obtained from the subject, ii) comparing the level determined at step i) with a predetermined reference value wherein detecting differential between the level of CD73 expression by DP8? TREGS determined at step i) and the predetermined reference value is indicative of whether a subject has or is at a risk of developing graft-versus-host disease (GvHD).

Keywords: Graft-versus-host disease, Prognosis, CD73 expression on Treg cells, hematological malignancies, allogeneic hematopoietic stem cell transplantation
Patent Application number: European Procedure (Patents) (EPA) - 04 Nov. 2020 - 20 306 320.1
Inventors:
GODEFROY EmmanuelleCHEVALLIER PatriceALTARE FrédéricJOTEREAU Francine

Reference:

BIO20418-D1

Business Developper
contact
Inserm Transfert
Business Developer
Patent filling date: 04-11-2020
Rare disease: No
Second indication: No

You might also be interested in